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Introduction {#sec001}
============

*Vibrio parahaemolyticus* is a gram-negative halophilic human pathogen that naturally occurs in marine or estuarine environments, which is frequently isolated from a variety of seafood, such as shrimp, oyster, and fish \[[@pone.0180335.ref001]--[@pone.0180335.ref003]\]. Infections caused by *V*. *parahaemolyticus* can cause acute human gastroenteritis with major symptoms of headache, abdominal pain, and diarrhea, and in some cases, wound infection and septicemia \[[@pone.0180335.ref004]--[@pone.0180335.ref006]\]. This foodborne pathogen is considered the leading cause of seafood-derived illness in many countries around the world, including the United States, Thailand, Malaysia, Japan, Korea, and China \[[@pone.0180335.ref006]--[@pone.0180335.ref009]\]. In China, a total of 322 gastroenteritis outbreaks involving 9,041 illnesses and 3,948 hospitalizations due to *V*. *parahaemolyticus* infection were reported from 2003 to 2008 \[[@pone.0180335.ref010]\].

Zhoushan Fishery is the largest fishery in China. The output of aquatic products in Zhoushan is around 1.3 million tons annually, meanwhile, the offshore ocean fishing output account formore than one tenth of the total output in China \[[@pone.0180335.ref011]\]. Many citizens of Zhoushan in China regularly consume raw or undercooked seafood. Therefore, *V*. *parahaemolyticus* is a common regional pathogen, which causes more than 70% of the food-poisoning cases in Zhoushan \[[@pone.0180335.ref012]\]. Despite the high risk of *V*. *parahaemolyticus*, information regarding the prevalence or molecular epidemiology of this pathogen is not readily available.

The main objective of the present study was to investigate *V*. *parahaemolyticus* strains collected from stool specimens of outpatients with diarrheal disease in Zhoushan hospitals and to analyze their serotypes, virulence genes, genotypic traits, and antimicrobial resistance. The investigation will provide vital information to government agencies for performing risk assessments of *V*. *parahaemolyticus* infections.

Materials and methods {#sec002}
=====================

Bacterial isolates {#sec003}
------------------

A total of 107 clinical *V*. *parahaemolyticus* isolates were used in the present study. They were collected from the stool specimens of 107 sporadic diarrhea outpatients from the active surveillance hospital: Zhoushan hospital. All isolates were collected from 2013 (41 isolates) to 2014 (66 isolates). The 107 isolates were stored at -80°C in trypticase soy broth (TSB) containing 20% glycerol for further analysis.

Analysis of virulence genes and Kanagawa phenomenon {#sec004}
---------------------------------------------------

*Vibrio parahaemolyticus* can be detected by a species-specific marker (*tlh*) with the pathogenic strains carrying an additional *tdh* and/or *trh* gene. In addition, a distinctive eighth open reading frame of the filamentous phage f237, *orf8*, has been suggested as an useful genetic marker for identification of those pathogenic strains \[[@pone.0180335.ref013]--[@pone.0180335.ref015]\].

Determination of *tlh tdh*, and *trh* genes as well as the marker (*orf8*) for the *V*. *parahaemolyticus* isolates was performed using multiplex polymerase chain reaction (PCR) according to the methods of Ward and Bej \[[@pone.0180335.ref016]\] ([Table 1](#pone.0180335.t001){ref-type="table"}). The pathogenic group was defined as *tdh*+ and/or *trh*+; all other isolates were assigned to the non-pathogenic group \[[@pone.0180335.ref015], [@pone.0180335.ref017]\].

10.1371/journal.pone.0180335.t001

###### Oligonucleotide primers used for polymerase chain reactions \[[@pone.0180335.ref016]\].

![](pone.0180335.t001){#pone.0180335.t001g}

  -----------------------------------------------------------------------------------------
  Target genes    Primers (Probes)                 Sequence (5'-3')             Amplicon\
                                                                                Size (bp)
  --------------- -------------------------------- ---------------------------- -----------
  *tlh*           F-tl                             `AAAGCGGATTATGCAGAAGCACTG`   450

  R-tl            `GCTACTTTCTAGCATTTTCTCTGC`                                    

  P-tl952         `AAGAACTTCATGTTGATGACACT`                                     

  *tdh*           F-*tdh*170DG                     `GTAAAGGTCTCTGACTTTTGGAC`    229

  R-*tdh*403      `CTACAGAATCATAGGAATGTTGAAG`                                   

  P-*tdh*-341R    `ATTTTACGAACACAGCAGAATGA`                                     

  *trh*           F-*trh*82                        `CCATCAATACCTTTTCCTTCTCC`    207

  R-*trh*287c     `ACCGTCATATAGGCGCTTAAC`                                       

  P-*trh*275      `TATTTGTCGTTAGAAATACAACAAT`                                   

  *orf8*          F-O3MM824                        `AGGACGCAGTTACGCTTGATG`      369

  R-O3MM1192      `CTAACGCATTGTCCCTTTGTAG`                                      

  P-ORFORF8-853   `AAGCCATTAACAGTTGAAGGCGTTGACT`                                
  -----------------------------------------------------------------------------------------

Analysis of the Kanagawa phenomenon produced by the *V*. *parahaemolyticus* isolates was conducted using Wagatsuma blood agar (OXOID, Cambridge, UK) according to China National Food Safety Standard methods, GB 4789.7--2013. Each *V*. *parahaemolyticus* isolate was cultured on a plate of tryptic soy agar (OXOID, Cambridge, UK) containing 3% NaCl for 18 h and then spotted on a Wagatsuma agar plate. The Wagatsuma agar plates were incubated for 18--24 h at 37°C and examined for Kanagawa phenomenon within 24 h.

Serotyping {#sec005}
----------

Serological analysis of lipopolysaccharide (O) and capsular (K) antigens of the *V*. *parahaemolyticus* isolates was identified by performing agglutination tests using a commercial *V*. *parahaemolyticus* antiserum test kit (Denka Seiken, Tokyo, Japan) according to the manufacturer's instructions.

Pulsed-field gel electrophoresis (PFGE) {#sec006}
---------------------------------------

The PFGE analysis of the *V*. *parahaemolyticus* isolates was performed according to the PulseNet protocol ([http://www.pulsenetinternational.org](http://www.pulsenetinternational.org/)). Briefly, using *Not*I enzyme to restrict the chromosomal DNA. The restriction fragments were resolved with 1% seakem gold agarose gel in 0.5% Tris-boric acid-EDTA buffer using a CHEF Mapper XA system (Bio-Rad Laboratories, Richmond, Calif., USA). The *Xba*I digested DNA from *Salmonella enterica* serotype Braenderup strain H9812 was used as a molecular size marker. The PFGE patterns were analyzed using BioNumerics software (Applied Maths, Belgium). Clustering was performed using the unweighted pair group method and the Dice correlation coefficient with a position tolerance of 1.5%. Clusters were defined on the basis of a 90% similarity cutoff \[[@pone.0180335.ref018]\].

Antimicrobial susceptibility testing {#sec007}
------------------------------------

The antimicrobial susceptibility of the 107 clinical *V*. *parahaemolyticus* isolates was tested using the broth microdilution method. The results of antimicrobial susceptibility were interpreted as sensitive, intermediate, or resistant, according to the Clinical and Laboratory Standards Institute (CLSI) breakpoint for *Vibrio* species (not *V*. *cholerae*). *Escherichia coli* ATCC 25922 was used as a control. The results were analyzed using the CLSI breakpoints.

Results {#sec008}
=======

Distribution of pathogenic and non-pathogenic strains {#sec009}
-----------------------------------------------------

All of the 107 clinical isolates (100%, 107/107) were positive for the *tlh* gene, among which there were 94 isolates (87.9%, 94/107) carrying the *tdh* gene, and only 4 isolates (3.7%, 4/107) carrying the *trh* gene. In addition, 12 isolates (11.2%, 12/107) isolated from the diarrheal patients were non-pathogenic strains containing neither the *tdh* gene nor the *trh* gene, whereas 92 (86.0%, 92/107) of the tested isolates were classified as pathogenic strains.

28 isolates (26.2%, 28/107) carried the *orf8* gene. 12 isolates (11.2%, 12/107) were determined to carry no *tdh*, *trh*, or *orf8* genes. Analysis of the Kanagawa phenomenon (KP) and molecular detection of virulence genes by PCR of the 107 *V*. *parahaemolyticus* isolates revealed high percentages of clinical isolates producing KP (80/107, 74.8%) and carrying the *tdh* gene (87.9%, 94/107). Among them, 79 isolates (73.8%, 79/107) were positive for both KP and the *tdh* gene and 3 isolates (2.8%) were positive for both KP and the *trh* gene.

Serotyping {#sec010}
----------

Serological analysis of the 107 *V*. *parahaemolyticus* isolates revealed a total of 10 serovars with O4:K8 (33.6%, 36/107) being the most common one followed by O3:K6 (29.0%, 31/107). These results indicate an increase in the occurrence of O3:K6 strains from 17.1% (7/41) in 2013 to 36.4% (24/66) in 2014 ([Fig 1](#pone.0180335.g001){ref-type="fig"}). However, the occurrence of the O4:K8 strains decreased from 51.2% (21/41) in 2013 to 22.7% (15/66) in 2014.

![Serological analysis of clinical *V*. *parahaemolyticus* isolates from patients in Zhoushan in 2013 (n = 41) and 2014 (n = 66).](pone.0180335.g001){#pone.0180335.g001}

Although all of the 107 isolates were each identified for its O antigen, 40 isolates with 8 (O) serotypes could not be serotyped for K antisera \[O4:KUT (20), O1:KUT (6), O3:KUT (5), O10:KUT (3), O5:KUT (2), O12:KUT (2), O2:KUT (1), and O11:KUT (1)\]. Among them, only two serotypes (O3:KUT and O4:KUT) were detected in the 2013 isolates, while all of the 8 serotypes were observed in the 2014 isolates ([Table 2](#pone.0180335.t002){ref-type="table"}).

10.1371/journal.pone.0180335.t002

###### Serotypes and virulence factors of 107 clinical *V*. *parahaemolyticus* isolated from patients in Zhoushan between 2013 and 2014.

![](pone.0180335.t002){#pone.0180335.t002g}

  O serogroups   Serovars   No. of isolate (s)   Virulence index             
  -------------- ---------- -------------------- ----------------- ---- ---- ----
  O1             O1:KUT     1                    \+                \+   −    \+
  1              \+         −                    −                 \+        
  4              −          −                    −                 −         
  O2             O2:KUT     1                    −                 −    −    \+
  O3             O3:K6      18                   \+                −    \+   \+
  4              \+         −                    \+                −         
  8              \+         −                    −                 \+        
  1              \+         −                    −                 −         
  O3:KUT         2          \+                   −                 −    \+   
  3              −          −                    −                 −         
  O4             O4:K8      2                    \+                −    \+   \+
  32             \+         −                    −                 \+        
  2              \+         −                    −                 −         
  O4:KUT         2          \+                   −                 \+   \+   
  1              \+         −                    \+                −         
  10             \+         −                    −                 \+        
  7              \+         −                    −                 −         
  O5             O5:KUT     2                    −                 −    −    −
  O10            O10:KUT    2                    \+                \+   −    \+
  1              −          −                    −                 −         
  O11            O11:KUT    1                    −                 \+   −    −
  O12            O12:KUT    1                    \+                −    \+   \+
  1              −          −                    −                 −         

^a^ Associated with pandemic isolates.

PFGE and cluster analysis {#sec011}
-------------------------

Analysis of the genotypes of the 107 clinical *V*. *parahaemolyticus* isolates found that 4 of the isolates were non-typable due to DNA degradation during endonuclease digestion. PFGE analysis of the remaining 103 isolates yielded 23 distinguishable patterns at a 90% similarity threshold ([Fig 2](#pone.0180335.g002){ref-type="fig"}). Among them, 35 isolates were clustered in pattern 9, which contained isolates belonging to two different serotypes, O4:K8 and O4:KUT. Furthermore, the isolates, which were O3:K6 serotype were not all included in the same group, such as VP012 and VP029 were clustered in pattern 14 and the other O3:K6 isolates were clustered in pattern 10, 11, 12 and 13.

![Pulsed-field gel electrophoresis of NotI-digested genomic DNA of selected clinical and foodborne *V*. *parahaemolyticus* isolates obtained in Zhoushan.\
Strain identification number, isolation date, and seromarkers.](pone.0180335.g002){#pone.0180335.g002}

Antimicrobial resistance profile {#sec012}
--------------------------------

The antimicrobial susceptibilities of *V*. *parahaemolyticus* are listed in [Table 3](#pone.0180335.t003){ref-type="table"}. The largest proportion of *V*. *parahaemolyticus* strains was resistant to ampicillin (85.5%, 91/106). More than half of the isolates exhibited intermediate levels of susceptibility to cefazolin (54.7%, 58/106). Additionally, more than 94% of the isolates were sensitive to other antimicrobials including gentamicin, amikacin, meropenem, imipenem, cefoxitin, cefepime, ceftazidime, trimethoprim/sulfamethoxazole, chloramphenicol, amoxicillin/clavulanic acid, ciprofloxacin, levofloxacin and tetracycline.

10.1371/journal.pone.0180335.t003

###### Antimicrobial susceptibility testing of 107 *V*. *parahaemolyticus* strains.

![](pone.0180335.t003){#pone.0180335.t003g}

  Antimicrobial agent             Susceptible (%)   Intermediate (%)   Resistant (%)
  ------------------------------- ----------------- ------------------ ---------------
  Gentamicin                      94.4              4.7                0.9
  Amikacin                        96.2              3.8                0.0
  Meropenem                       100.0             0.0                0.0
  Imipenem                        100.0             0.0                0.0
  Cefoxitin                       100.0             0.0                0.0
  Cefepime                        99.1              0.9                0.0
  Ceftazidime                     100.0             0.0                0.0
  Cefazolin                       45.3              54.7               0.0
  Trimethoprim/sulfamethoxazole   100.0             0.0                0.0
  Chloramphenicol                 100.0             0.0                0.0
  Amoxicillin/clavulanic acid     100.0             0.0                0.0
  Ampicillin                      0.0               14.2               85.8
  Ciprofloxacin                   100.0             0.0                0.0
  Levofloxacin                    100.0             0.0                0.0
  Tetracycline                    100.0             0.0                0.0

Discussion {#sec013}
==========

*V*. *parahaemolyticus* has emerged as an important public health concern worldwide as a pathogen that causes gastroenteritis related to the consumption of various seafood, including crab, shrimp, lobster, fish, and oysters \[[@pone.0180335.ref019]\]. In the present study, 107 clinical *V*. *parahaemolyticus* strains were collected from 2013 to 2014 in Zhoushan, we identified and analyzed the virulence genes, serotypes, molecular typing by PFGE, and antimicrobial resistance profiles of these clinical strains.

As shown by epidemiological investigation, thermostable direct hemolysin (TDH) is recognized as one of the major pathogenic factors in *V*. *parahaemolyticus*, and is present in 92% to 95% clinical isolates \[[@pone.0180335.ref019], [@pone.0180335.ref020]\], and it contributes to the formation the "Kanagawa phenomenon" (KP) \[[@pone.0180335.ref019]\], which has been regarded as an important indicator for the identification of pathogenic and non-pathogenic strains \[[@pone.0180335.ref019]\]. In the present study, among 94 *tdh*+ clinical strains, 15 strains did not show KP, moreover, we found one clinical strain (1/107) that tested positive for KP, though it carried neither *tdh* nor *trh*. Therefore, the KP is not a reliable indicator for identifying pathogenic and non-pathogenic *V*. *parahaemolyticus* strains \[[@pone.0180335.ref019]\].

As shown in [Table 2](#pone.0180335.t002){ref-type="table"}, 87.9% of the strains carried *tdh*, and only 4 strains carried *trh*, that is, 91.5% of the strains carried *tdh* and/or *trh* gene. This is similar to a previous study reporting 92.5% of the clinical isolates of *V*. *parahaemolyticus* collected in Shanghai as carrying the *tdh* and/or *trh* gene \[[@pone.0180335.ref020]\]. Furthermore, 11.2% of clinical strains from the diarrheal patients contained neither the *tdh* nor the *trh* gene, which is similar to a previous study reporting 11.8% of clinical isolates of *V*. *parahaemolyticus* collected in Jiangsu province as carrying neither the *tdh* gene nor the *trh* gene \[[@pone.0180335.ref015]\]. It has been reported that there were outbreaks caused by strains lacking of *tdh* and/or *trh* \[[@pone.0180335.ref021]\]. Although other pathogenic factors have been recognized, such as type III secretion system 1 and 2 and biofilm formation, the understanding of pathogenicityis still incomplete \[[@pone.0180335.ref021]\]. Meanwhile, 28 strains contained *orf8*. The *orf8* is suggested to be a marker for detecting recent serotype O3:K6 and other pandemic group strains \[[@pone.0180335.ref016]\], which were considered as a good target for detection of pathogenic pandemic *V*. *parahaemolyticus* O3:K6 serotype strains. As shown in the current study, the hemolysin genes (*tdh* and *trh*) and *orf8* were tested, furthermore, more pandemic markers, such as *toxRS*/new and type III secretion system could be analyzed to reveal comprehensive pathogenic and pandemic characteristics of clinical *V*. *parahaemolyticus* strains in Zhoushan.

Since *V*. *parahaemolyticus* was discovered 60 years ago \[[@pone.0180335.ref022]\], it has been considered as a major cause of foodborne illnesses all over the world with serotype O3:K6 being firstly isolated in 1996 in India and subsequently worldwide \[[@pone.0180335.ref015], [@pone.0180335.ref023]\]. In this study, 31 (29%) of 107 clinical *V*. *parahaemolyticus* isolates collected over 2 years from 2013 to 2014 were identified as O3:K6, which is lower than the previous study reporting 54%, 62% and 66% of the clinical isolates of *V*. *parahaemolyticus* collected in Guangdong, Shanghai and Jiangsu respectively \[[@pone.0180335.ref015], [@pone.0180335.ref020], [@pone.0180335.ref024]\]. These results demonstrate that *V*. *parahaemolyticus* strains with different serotypes can share common molecular types, therefore, the serotyping was of limited use because there was no match between serotype and PFGE cluster. PFGE has been used as the "gold standard" method to assess genetic diversity and clonal relatedness among *V*. *parahaemolyticus* isolates from different sources \[[@pone.0180335.ref018], [@pone.0180335.ref020], [@pone.0180335.ref025]\].

Antibiotics can be used to treat *V*. *parahaemolyticus* infection, and they should be based on the antimicrobial susceptibilities of *V*. *parahaemolyticus*. In the present study, most isolates were sensitive to the antimicrobial agents recommended by CLSI for *Vibrio* species (not V. cholerae) except ampicillin (85.8%). Similar findings have been reported by Chen et al (87.1%) \[[@pone.0180335.ref017]\]. As shown in [Table 3](#pone.0180335.t003){ref-type="table"}, 100% of the clinical strains in the present study were susceptible to Meropenem, Imipenem, Cefoxitin, Ceftazidime, Trimethoprim/sulfamethoxazole, Chloramphenicol, Amoxicillin/clavulanic acid, Ciprofloxacin, Levofloxacin and Tetracycline.

To the best of our knowledge, this is the first study to investigate virulence factors, serotypes, genotypes, and antimicrobial susceptibility of the clinical strains of *V*. *parahaemolyticus* collected in Zhoushan over 2 years through a continuous surveillance of *V*. *parahaemolyticus* isolated from patients during warm months. Continuous monitoring of *V*. *parahaemolyticus* strains in Zhoushan is necessary to generate information useful for the control of foodborne illnesses caused by *V*. *parahaemolyticus*.

Conclusions {#sec014}
===========

This study analyzed characteristics of *V*. *parahaemolyticus* strains in diarrheal patients in Zhoushan. Different serotypes were detected in the clinical isolates. Although the clinical *V*. *parahaemolyticus* strains isolated in Zhoushan are not resistant to most common antimicrobial agents, it will be necessary to keep a close attention to the emergence of antimicrobial resistant strains and strengthen the management of antimicrobials. Therefore, this information is useful for the control and treatment of foodborne illnesses caused by *V*. *parahaemolyticus* in Zhoushan.
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